...
首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Successful treatment of upper-left eyelid squamous cell carcinoma in an epidermodysplasia verruciformis patient by ALA-PDT/holmium laser combination therapy
【24h】

Successful treatment of upper-left eyelid squamous cell carcinoma in an epidermodysplasia verruciformis patient by ALA-PDT/holmium laser combination therapy

机译:通过ALA-PDT /钬激光组合疗法成功治疗表皮型鳞癌患者的左上眼睑鳞状细胞癌

获取原文
获取原文并翻译 | 示例
           

摘要

Epidermodysplasia verruciformis (EV) is a rare autosomal recessive disorder. Individuals with EV are more susceptible to the development of cutaneous neoplasia in sun-exposed regions. This disease should be closely observed for cutaneous squamous cell carcinoma (cSCC) or pre-cancerous lesions - if neoplasia is found, it should be removed. A 68-year-old woman with EV had a post-operative recurrent, invasive cSCC growing on her upper-left eyelid. Although the standard treatment for cSCC is surgical excision, it is challenging to reach the deepest regions. Herein, we reported a case of a recurrent, invasive cSCC effectively treated by a combination of non-invasive 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) and deep-penetrative holmium laser. The results were satisfactory without any adverse effects to the patient.
机译:Epidermodysplasia verruciformis(EV)是一种罕见的常染色体隐性疾病。 具有EV的个体更容易发生太阳暴露的地区皮肤肿瘤的发展。 对于皮肤鳞状细胞癌(CSCC)或预癌性病变,应密切关注这种疾病 - 如果发现肿瘤,则应除去。 一个68岁的女性患有EV的后期患者复发性CSCC在她的左上眼睑上生长。 虽然CSCC的标准治疗是手术切除,但到达最深的地区是挑战性的。 在此,我们报道了一种经复制的侵袭性CSCC的情况,通过非侵入式5-氨基纤维酸介导的光动力治疗(ALA-PDT)和深渗透钬激光器的组合有效处理。 结果令人满意,对患者没有任何不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号